title: Nafarelin in the treatment of endometriosis. Dose management.
abstract: Nafarelin, a gonadotropin-releasing hormone agonist, has been shown to be effective in the treatment of endometriosis. The standard dosage is 200 micrograms bid intranasally. Side effects most commonly include those associated with estrogen deprivation. By assessing estrogen status, the standard dosage can be manipulated to minimize these side effects and increase patient compliance.
authors.affiliation: Department of Obstetrics and Gynecology, SUNY at Stony Brook 11794.
authors.forename: M E
authors.initials: ME
authors.lastname: Hull
authors.forename: R L
authors.initials: RL
authors.lastname: Barbieri
mesh_terms: D000281:Administration, Intranasal; D000328:Adult; D000698:Analgesia; D004715:Endometriosis / Q000097:blood / Q000188:drug therapy*; D004958:Estradiol / Q000097:blood; D005260:Female; D006801:Humans; D017274:Nafarelin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D017699:Pelvic Pain; D014592:Uterine Hemorrhage
chemical_list: D017274:Nafarelin; D004958:Estradiol